TNM Expanding Set of Target Indications​

EFFICACY PoC already obtained in mice-bearing CRC, pancreatic cancer, melanoma, triple negative breast cancer (TNBC) or glioblastoma.​

• EXTENSIVE INFILTRATION of EFFECTOR IMMUNE CELLS in the tumor microenvironment of several solid tumors – ANTIGEN SPECIFIC IMMUNE-MEDIATED CYTOTOXIC EFFECT​